Literature DB >> 16142316

Trefoil factor family mRNA and protein expression in pterygium.

Pierre-Olivier Lafontaine1, Murielle Arnal, Nelly Buron, Eric Solary, Alain M Bron, Bruce R Westley, Felicity E B May, Jacques Bara, Christian Gespach, Catherine Creuzot-Garcher.   

Abstract

Trefoil factor family (TFF) of proteins are involved in mucosal protection and healing and are induced in inflammatory diseases and neoplastic progression. The purpose of this investigation was to determine if expression of the trefoil factor family (TFF) proteins is altered in human pterygium compared to in normal conjunctiva. Fourteen pterygia (P) and 21 biopsies from normal human conjunctiva (NC) were studied. TFF1, TFF2 and TFF3 mRNA levels were measured by semi-quantitative reverse-transcription polymerase chain reaction (RT-PCR), and TFF1 mRNA levels in addition by real-time PCR. The cellular expression of TFF1 (pS2), TFF3 (intestinal trefoil factor) and M1/MUC5AC mucin in ten pterygia and ten normal human conjunctiva specimens was analyzed by immunohistochemistry using specific monoclonal antibodies. TFF1 mRNA levels were higher in P than in NC (p=0.02). Accordingly, intensity of TFF1 and mucin MUC5AC immunostaining was higher in P than in NC. Mucus-secreting goblet cells (GC) were more densely packed in P than in NC. In both cases, TFF1 protein was detected in GC only, but was not systematically expressed in all GC. In addition, TFF3 mRNA levels were similar (p=0.89) in NC and P, while TFF2 (spasmolytic polypeptide) mRNA were not detected. Both TFF3 and MUC5AC proteins were clearly detected in all GC identified in NC and P. Increased expression of TFF1 mRNA and protein is observed in pterygium GC, suggesting that this trefoil protein might exert protective and beneficial roles during the pathogenesis of this benign and inflammatory conjunctival tumor.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16142316

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  6 in total

1.  Differentiating the undifferentiated: immunohistochemical profile of medullary carcinoma of the colon with an emphasis on intestinal differentiation.

Authors:  Brody Winn; Rosemarie Tavares; Jacqueline Fanion; Lelia Noble; John Gao; Edmond Sabo; Murray B Resnick
Journal:  Hum Pathol       Date:  2008-11-07       Impact factor: 3.466

2.  Decreased expression of gastrokine 1 and the trefoil factor interacting protein TFIZ1/GKN2 in gastric cancer: influence of tumor histology and relationship to prognosis.

Authors:  Steven F Moss; Jin-Woo Lee; Edmond Sabo; Anna K Rubin; John Rommel; Bruce R Westley; Felicity E B May; John Gao; Patricia A Meitner; Rose Tavares; Murray B Resnick
Journal:  Clin Cancer Res       Date:  2008-07-01       Impact factor: 12.531

3.  The interaction of Helicobacter pylori with the adherent mucus gel layer secreted by polarized HT29-MTX-E12 cells.

Authors:  Brendan Dolan; Julie Naughton; Nicole Tegtmeyer; Felicity E B May; Marguerite Clyne
Journal:  PLoS One       Date:  2012-10-08       Impact factor: 3.240

4.  Transcriptomics and network analysis highlight potential pathways in the pathogenesis of pterygium.

Authors:  Juliana Albano de Guimarães; Bidossessi Wilfried Hounpke; Bruna Duarte; Ana Luiza Mylla Boso; Marina Gonçalves Monteiro Viturino; Letícia de Carvalho Baptista; Mônica Barbosa de Melo; Monica Alves
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.379

5.  Distinct gene subsets in pterygia formation and recurrence: dissecting complex biological phenomenon using genome wide expression data.

Authors:  Louis Tong; Jaime Chew; Henry Yang; Leonard P K Ang; Donald T H Tan; Roger W Beuerman
Journal:  BMC Med Genomics       Date:  2009-03-10       Impact factor: 3.063

6.  Gene expression profiling of naïve sheep genetically resistant and susceptible to gastrointestinal nematodes.

Authors:  Orla M Keane; Amonida Zadissa; Theresa Wilson; Dianne L Hyndman; Gordon J Greer; David B Baird; Alan F McCulloch; Allan M Crawford; John C McEwan
Journal:  BMC Genomics       Date:  2006-03-06       Impact factor: 3.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.